世界の血球凝集素5市場2026:インサイト・予測

QYResearchが発行した調査報告書(QYR20NV01110)
◆英語タイトル:Global Hemagglutinin 5 Market Insights and Forecast to 2026
◆商品コード:QYR20NV01110
◆発行会社(リサーチ会社):QYResearch
◆発行日:2020年11月(※2024年版があります。お問い合わせください。)
◆ページ数:118
◆レポート形式:英語 / PDF
◆納品方法:Eメール(受注後3営業日)
◆調査対象地域:グローバル
◆産業分野:医療、製薬
◆販売価格オプション(消費税別)
Single User(1名様閲覧用)USD3,900 ⇒換算¥577,200見積依頼/購入/質問フォーム
Multi User(5名様閲覧用)USD5,850 ⇒換算¥865,800見積依頼/購入/質問フォーム
Enterprise License(同一法人内共有可)USD7,800 ⇒換算¥1,154,400見積依頼/購入/質問フォーム
販売価格オプションの説明はこちらでご利用ガイドはこちらでご確認いただけます。
※お支払金額は「換算金額(日本円)+消費税+配送料(Eメール納品は無料)」です。
※本体価格が¥30,000未満のレポートにつきましては、ハンドリングチャージ¥5,000が別途かかります。
※Eメールによる納品の場合、通常ご注文当日〜2日以内に納品致します。
※レポート納品後、納品日+5日以内に請求書を発行し、お客様宛に郵送いたしますので、請求書発行日より2ヶ月以内に銀行振込にて支払をお願いします。
※上記の日本語題名はH&Iグローバルリサーチが翻訳したものです。英語版原本には日本語表記はありません。
※為替レートは適宜修正・更新しております。リアルタイム更新ではありません。
※弊社H&Iグローバルリサーチ株式会社はQYResearch社の日本における正規代理店です。同社発行の市場リサーチレポート及びリサーチサービスに関するお問い合わせは弊社までお願い致します。QYResearch社の概要及び新刊レポートはこちらでご確認いただけます。

本調査レポートは血球凝集素5の世界市場について調査・分析した資料です。種類別(VGX-3400X、IY-7640、INO-3510、DPC-005、その他)の市場規模、用途別(クリニック、病院、家庭)の市場規模、地域別(北米、米国、カナダ、ヨーロッパ、ドイツ、フランス、イギリス、イタリア、ロシア、アジア、日本、中国、韓国、インド、オーストラリア、台湾、中南米、メキシコ、ブラジル、アルゼンチン、中東・アフリカ、トルコ、サウジアラビア、UAE等)の市場規模データ、主な企業情報と企業別市場シェア等が記載されています。
・調査範囲
・エグゼクティブサマリー
・企業別血球凝集素5の競争状況、市場シェア
・世界の血球凝集素5市場:種類別市場規模 2015年-2020年(VGX-3400X、IY-7640、INO-3510、DPC-005、その他)
・世界の血球凝集素5市場:種類別市場規模予測 2021年-2026年(VGX-3400X、IY-7640、INO-3510、DPC-005、その他)
・世界の血球凝集素5市場:用途別市場規模 2015年-2020年(クリニック、病院、家庭)
・世界の血球凝集素5市場:用途別市場規模予測 2021年-2026年(クリニック、病院、家庭)
・北米の血球凝集素5市場分析:米国、カナダ
・ヨーロッパの血球凝集素5市場分析:ドイツ、フランス、イギリス、イタリア、ロシア等
・アジアの血球凝集素5市場分析:日本、中国、韓国、インド、オーストラリア、台湾等
・中南米の血球凝集素5市場分析:メキシコ、ブラジル、アルゼンチン等
・中東・アフリカの血球凝集素5市場分析:トルコ、サウジアラビア、UAE等
・企業情報(企業概要、製品概要、販売量、企業動向)
- 掲載企業(変更可能性あり):Altravax, Inc.、Ilyang Pharmaceutical Co., Ltd、Inovio Pharmaceuticals, Inc.、NewLink Genetics Corporation、Vaxine Pty Ltd
・地域別市場規模予測(2021年-2026年):北米市場、ヨーロッパ市場、アジア市場、中南米市場、中東・アフリカ市場
・市場機会、課題、リスク、環境分析
・バリューチェーン、販売チャネル分析
・調査の結論
【レポートの概要】

Market Analysis and Insights: Global Hemagglutinin 5 Market
The global Hemagglutinin 5 market size is projected to reach US$ XX million by 2026, from US$ XX million in 2020, at a CAGR of XX%% during 2021-2026.

Global Hemagglutinin 5 Scope and Market Size
Hemagglutinin 5 market is segmented by Type, and by Application. Players, stakeholders, and other participants in the global Hemagglutinin 5 market will be able to gain the upper hand as they use the report as a powerful resource. The segmental analysis focuses on sales, revenue and forecast by Type and by Application for the period 2015-2026.

Segment by Type, the Hemagglutinin 5 market is segmented into
VGX-3400X
IY-7640
INO-3510
DPC-005
Others

Segment by Application, the Hemagglutinin 5 market is segmented into
Clinic
Hospital
House Use

Regional and Country-level Analysis
The Hemagglutinin 5 market is analysed and market size information is provided by regions (countries).
The key regions covered in the Hemagglutinin 5 market report are North America, Europe, Asia Pacific, Latin America, Middle East and Africa. It also covers key regions (countries), viz, U.S., Canada, Germany, France, U.K., Italy, Russia, China, Japan, South Korea, India, Australia, Taiwan, Indonesia, Thailand, Malaysia, Philippines, Vietnam, Mexico, Brazil, Turkey, Saudi Arabia, U.A.E, etc.
The report includes country-wise and region-wise market size for the period 2015-2026. It also includes market size and forecast by Type, and by Application segment in terms of sales and revenue for the period 2015-2026.
Competitive Landscape and Hemagglutinin 5 Market Share Analysis
Hemagglutinin 5 market competitive landscape provides details and data information by players. The report offers comprehensive analysis and accurate statistics on revenue by the player for the period 2015-2020. It also offers detailed analysis supported by reliable statistics on revenue (global and regional level) by players for the period 2015-2020. Details included are company description, major business, company total revenue and the sales, revenue generated in Hemagglutinin 5 business, the date to enter into the Hemagglutinin 5 market, Hemagglutinin 5 product introduction, recent developments, etc.

The major vendors covered:
Altravax, Inc.
Ilyang Pharmaceutical Co., Ltd
Inovio Pharmaceuticals, Inc.
NewLink Genetics Corporation
Vaxine Pty Ltd

【レポートの目次】

1 Study Coverage
1.1 Hemagglutinin 5 Product Introduction
1.2 Market Segments
1.3 Key Hemagglutinin 5 Manufacturers Covered: Ranking by Revenue
1.4 Market by Type
1.4.1 Global Hemagglutinin 5 Market Size Growth Rate by Type
1.4.2 VGX-3400X
1.4.3 IY-7640
1.4.4 INO-3510
1.4.5 DPC-005
1.4.6 Others
1.5 Market by Application
1.5.1 Global Hemagglutinin 5 Market Size Growth Rate by Application
1.5.2 Clinic
1.5.3 Hospital
1.5.4 House Use
1.6 Study Objectives
1.7 Years Considered

2 Executive Summary
2.1 Global Hemagglutinin 5 Market Size, Estimates and Forecasts
2.1.1 Global Hemagglutinin 5 Revenue 2015-2026
2.1.2 Global Hemagglutinin 5 Sales 2015-2026
2.2 Global Hemagglutinin 5, Market Size by Producing Regions: 2015 VS 2020 VS 2026
2.2.1 Global Hemagglutinin 5 Retrospective Market Scenario in Sales by Region: 2015-2020
2.2.2 Global Hemagglutinin 5 Retrospective Market Scenario in Revenue by Region: 2015-2020

3 Global Hemagglutinin 5 Competitor Landscape by Players
3.1 Hemagglutinin 5 Sales by Manufacturers
3.1.1 Hemagglutinin 5 Sales by Manufacturers (2015-2020)
3.1.2 Hemagglutinin 5 Sales Market Share by Manufacturers (2015-2020)
3.2 Hemagglutinin 5 Revenue by Manufacturers
3.2.1 Hemagglutinin 5 Revenue by Manufacturers (2015-2020)
3.2.2 Hemagglutinin 5 Revenue Share by Manufacturers (2015-2020)
3.2.3 Global Hemagglutinin 5 Market Concentration Ratio (CR5 and HHI) (2015-2020)
3.2.4 Global Top 10 and Top 5 Companies by Hemagglutinin 5 Revenue in 2019
3.2.5 Global Hemagglutinin 5 Market Share by Company Type (Tier 1, Tier 2 and Tier 3)
3.3 Hemagglutinin 5 Price by Manufacturers
3.4 Hemagglutinin 5 Manufacturing Base Distribution, Product Types
3.4.1 Hemagglutinin 5 Manufacturers Manufacturing Base Distribution, Headquarters
3.4.2 Manufacturers Hemagglutinin 5 Product Type
3.4.3 Date of International Manufacturers Enter into Hemagglutinin 5 Market
3.5 Manufacturers Mergers & Acquisitions, Expansion Plans

4 Market Size by Type (2015-2026)
4.1 Global Hemagglutinin 5 Market Size by Type (2015-2020)
4.1.1 Global Hemagglutinin 5 Sales by Type (2015-2020)
4.1.2 Global Hemagglutinin 5 Revenue by Type (2015-2020)
4.1.3 Hemagglutinin 5 Average Selling Price (ASP) by Type (2015-2026)
4.2 Global Hemagglutinin 5 Market Size Forecast by Type (2021-2026)
4.2.1 Global Hemagglutinin 5 Sales Forecast by Type (2021-2026)
4.2.2 Global Hemagglutinin 5 Revenue Forecast by Type (2021-2026)
4.2.3 Hemagglutinin 5 Average Selling Price (ASP) Forecast by Type (2021-2026)
4.3 Global Hemagglutinin 5 Market Share by Price Tier (2015-2020): Low-End, Mid-Range and High-End

5 Market Size by Application (2015-2026)
5.1 Global Hemagglutinin 5 Market Size by Application (2015-2020)
5.1.1 Global Hemagglutinin 5 Sales by Application (2015-2020)
5.1.2 Global Hemagglutinin 5 Revenue by Application (2015-2020)
5.1.3 Hemagglutinin 5 Price by Application (2015-2020)
5.2 Hemagglutinin 5 Market Size Forecast by Application (2021-2026)
5.2.1 Global Hemagglutinin 5 Sales Forecast by Application (2021-2026)
5.2.2 Global Hemagglutinin 5 Revenue Forecast by Application (2021-2026)
5.2.3 Global Hemagglutinin 5 Price Forecast by Application (2021-2026)

6 North America
6.1 North America Hemagglutinin 5 by Country
6.1.1 North America Hemagglutinin 5 Sales by Country
6.1.2 North America Hemagglutinin 5 Revenue by Country
6.1.3 U.S.
6.1.4 Canada
6.2 North America Hemagglutinin 5 Market Facts & Figures by Type
6.3 North America Hemagglutinin 5 Market Facts & Figures by Application

7 Europe
7.1 Europe Hemagglutinin 5 by Country
7.1.1 Europe Hemagglutinin 5 Sales by Country
7.1.2 Europe Hemagglutinin 5 Revenue by Country
7.1.3 Germany
7.1.4 France
7.1.5 U.K.
7.1.6 Italy
7.1.7 Russia
7.2 Europe Hemagglutinin 5 Market Facts & Figures by Type
7.3 Europe Hemagglutinin 5 Market Facts & Figures by Application

8 Asia Pacific
8.1 Asia Pacific Hemagglutinin 5 by Region
8.1.1 Asia Pacific Hemagglutinin 5 Sales by Region
8.1.2 Asia Pacific Hemagglutinin 5 Revenue by Region
8.1.3 China
8.1.4 Japan
8.1.5 South Korea
8.1.6 India
8.1.7 Australia
8.1.8 Taiwan
8.1.9 Indonesia
8.1.10 Thailand
8.1.11 Malaysia
8.1.12 Philippines
8.1.13 Vietnam
8.2 Asia Pacific Hemagglutinin 5 Market Facts & Figures by Type
8.3 Asia Pacific Hemagglutinin 5 Market Facts & Figures by Application

9 Latin America
9.1 Latin America Hemagglutinin 5 by Country
9.1.1 Latin America Hemagglutinin 5 Sales by Country
9.1.2 Latin America Hemagglutinin 5 Revenue by Country
9.1.3 Mexico
9.1.4 Brazil
9.1.5 Argentina
9.2 Central & South America Hemagglutinin 5 Market Facts & Figures by Type
9.3 Central & South America Hemagglutinin 5 Market Facts & Figures by Application

10 Middle East and Africa
10.1 Middle East and Africa Hemagglutinin 5 by Country
10.1.1 Middle East and Africa Hemagglutinin 5 Sales by Country
10.1.2 Middle East and Africa Hemagglutinin 5 Revenue by Country
10.1.3 Turkey
10.1.4 Saudi Arabia
10.1.5 U.A.E
10.2 Middle East and Africa Hemagglutinin 5 Market Facts & Figures by Type
10.3 Middle East and Africa Hemagglutinin 5 Market Facts & Figures by Application

11 Company Profiles
11.1 Altravax, Inc.
11.1.1 Altravax, Inc. Corporation Information
11.1.2 Altravax, Inc. Description and Business Overview
11.1.3 Altravax, Inc. Sales, Revenue and Gross Margin (2015-2020)
11.1.4 Altravax, Inc. Hemagglutinin 5 Products Offered
11.1.5 Altravax, Inc. Related Developments
11.2 Ilyang Pharmaceutical Co., Ltd
11.2.1 Ilyang Pharmaceutical Co., Ltd Corporation Information
11.2.2 Ilyang Pharmaceutical Co., Ltd Description and Business Overview
11.2.3 Ilyang Pharmaceutical Co., Ltd Sales, Revenue and Gross Margin (2015-2020)
11.2.4 Ilyang Pharmaceutical Co., Ltd Hemagglutinin 5 Products Offered
11.2.5 Ilyang Pharmaceutical Co., Ltd Related Developments
11.3 Inovio Pharmaceuticals, Inc.
11.3.1 Inovio Pharmaceuticals, Inc. Corporation Information
11.3.2 Inovio Pharmaceuticals, Inc. Description and Business Overview
11.3.3 Inovio Pharmaceuticals, Inc. Sales, Revenue and Gross Margin (2015-2020)
11.3.4 Inovio Pharmaceuticals, Inc. Hemagglutinin 5 Products Offered
11.3.5 Inovio Pharmaceuticals, Inc. Related Developments
11.4 NewLink Genetics Corporation
11.4.1 NewLink Genetics Corporation Corporation Information
11.4.2 NewLink Genetics Corporation Description and Business Overview
11.4.3 NewLink Genetics Corporation Sales, Revenue and Gross Margin (2015-2020)
11.4.4 NewLink Genetics Corporation Hemagglutinin 5 Products Offered
11.4.5 NewLink Genetics Corporation Related Developments
11.5 Vaxine Pty Ltd
11.5.1 Vaxine Pty Ltd Corporation Information
11.5.2 Vaxine Pty Ltd Description and Business Overview
11.5.3 Vaxine Pty Ltd Sales, Revenue and Gross Margin (2015-2020)
11.5.4 Vaxine Pty Ltd Hemagglutinin 5 Products Offered
11.5.5 Vaxine Pty Ltd Related Developments
11.1 Altravax, Inc.
11.1.1 Altravax, Inc. Corporation Information
11.1.2 Altravax, Inc. Description and Business Overview
11.1.3 Altravax, Inc. Sales, Revenue and Gross Margin (2015-2020)
11.1.4 Altravax, Inc. Hemagglutinin 5 Products Offered
11.1.5 Altravax, Inc. Related Developments

12 Future Forecast by Regions (Countries) (2021-2026)
12.1 Hemagglutinin 5 Market Estimates and Projections by Region
12.1.1 Global Hemagglutinin 5 Sales Forecast by Regions 2021-2026
12.1.2 Global Hemagglutinin 5 Revenue Forecast by Regions 2021-2026
12.2 North America Hemagglutinin 5 Market Size Forecast (2021-2026)
12.2.1 North America: Hemagglutinin 5 Sales Forecast (2021-2026)
12.2.2 North America: Hemagglutinin 5 Revenue Forecast (2021-2026)
12.2.3 North America: Hemagglutinin 5 Market Size Forecast by Country (2021-2026)
12.3 Europe Hemagglutinin 5 Market Size Forecast (2021-2026)
12.3.1 Europe: Hemagglutinin 5 Sales Forecast (2021-2026)
12.3.2 Europe: Hemagglutinin 5 Revenue Forecast (2021-2026)
12.3.3 Europe: Hemagglutinin 5 Market Size Forecast by Country (2021-2026)
12.4 Asia Pacific Hemagglutinin 5 Market Size Forecast (2021-2026)
12.4.1 Asia Pacific: Hemagglutinin 5 Sales Forecast (2021-2026)
12.4.2 Asia Pacific: Hemagglutinin 5 Revenue Forecast (2021-2026)
12.4.3 Asia Pacific: Hemagglutinin 5 Market Size Forecast by Region (2021-2026)
12.5 Latin America Hemagglutinin 5 Market Size Forecast (2021-2026)
12.5.1 Latin America: Hemagglutinin 5 Sales Forecast (2021-2026)
12.5.2 Latin America: Hemagglutinin 5 Revenue Forecast (2021-2026)
12.5.3 Latin America: Hemagglutinin 5 Market Size Forecast by Country (2021-2026)
12.6 Middle East and Africa Hemagglutinin 5 Market Size Forecast (2021-2026)
12.6.1 Middle East and Africa: Hemagglutinin 5 Sales Forecast (2021-2026)
12.6.2 Middle East and Africa: Hemagglutinin 5 Revenue Forecast (2021-2026)
12.6.3 Middle East and Africa: Hemagglutinin 5 Market Size Forecast by Country (2021-2026)

13 Market Opportunities, Challenges, Risks and Influences Factors Analysis
13.1 Market Opportunities and Drivers
13.2 Market Challenges
13.3 Market Risks/Restraints
13.4 Porter’s Five Forces Analysis
13.5 Primary Interviews with Key Hemagglutinin 5 Players (Opinion Leaders)

14 Value Chain and Sales Channels Analysis
14.1 Value Chain Analysis
14.2 Hemagglutinin 5 Customers
14.3 Sales Channels Analysis
14.3.1 Sales Channels
14.3.2 Distributors

15 Research Findings and Conclusion

16 Appendix
16.1 Research Methodology
16.1.1 Methodology/Research Approach
16.1.2 Data Source
16.2 Author Details
16.3 Disclaimer

...

【掲載企業】

Altravax, Inc.、Ilyang Pharmaceutical Co., Ltd、Inovio Pharmaceuticals, Inc.、NewLink Genetics Corporation、Vaxine Pty Ltd

【免責事項】
https://www.globalresearch.jp/disclaimer

★リサーチレポート[ 世界の血球凝集素5市場2026:インサイト・予測(Global Hemagglutinin 5 Market Insights and Forecast to 2026)]についてメールでお問い合わせはこちらでお願いします。